IGF1R and metabolic syndrome: MKR mice, which possess a mutant dominant-negative insulin-like growth factor-1 receptor (KR-IGF-1R) specifically targeted to skeletal muscle, exhibit features of nonobese type 2 DM, such as hyperglycemia, dysinsulinemia and dyslipidemia (22), and reduced NCV, accompanied by hypoalgesia (23).